Daily non-political popular news in brief.

Targeting gut bugs could revolutionize future drugs, say researcher

02-01-2008 · EurekAlert!

Revolutionary new ways to tackle certain diseases could be provided by creating drugs which change the bugs in people's guts, according to a new article. Trillions of bugs known as gut microbes live symbiotically in the human gut. They play a key role in many of the processes that take place inside the body. Different people have different types of gut microbes living inside them and abnormalities in some types have recently been linked to diseases such as diabetes and obesity.

Keywords: targeting, gut, bugs, revolutionize, future, drugs, researcher, bug, drug

« Previous | Next »

Similar news on "Targeting gut bugs could revolutionize future drugs, say researcher":

Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
02-15-2008 · EurekAlert!
How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics -- selective estrogen receptor modulators. V. Craig Jordan, a researcher at the Fox Chase Cancer Center in Philadelphia, Jordan reports on efforts to use the lessons from tamoxifen to develop new hormone receptor-related drugs for both women and men.
Similar news · Read more »
Antifungal drug kills TB bug
03-12-2007 · EurekAlert!
Scientists hoping to find new treatments for one of the world’s most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.
Similar news · Read more »
HIV drug resistance risk in mothers reduced by combination of common drugs
11-09-2007 · EurekAlert!
Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
Similar news · Read more »
Bug guts map brings scientists closer to understanding different bugs' role in the body
02-05-2008 · EurekAlert!
Scientists have made a major step towards understanding precisely which bugs in the gut are involved in which processes in the body, by mapping the different species of bugs living in seven members of the same Chinese family.
Similar news · Read more »
Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
11-28-2007 · EurekAlert!
Sirtris Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including type 2 diabetes, by targeting SIRT1, a gene that controls the aging process.
Similar news · Read more »
Blocking cancer-causing gene improves radiation effectiveness, Jefferson researchers find
11-08-2006 · EurekAlert!
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they've shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.
Similar news · Read more »
Chemical maps hint at drug's effects on schizophrenia
05-15-2007 · EurekAlert!
Antipsychotic drugs do most of their work in the brain, but they also leave behind in the bloodstream a trail of hundreds of chemicals that may be used in the future to direct better treatment for schizophrenia and other psychiatric conditions, say Duke University Medical Center researchers.
Similar news · Read more »
Colon cancer screening -- Going 'Back To The Future'?
02-19-2007 · EurekAlert!
In an editorial in the February 20 edition of the Annals of Internal Medicine, Indiana University School of Medicine gastroenterologist and Regenstrief Institute, Inc. researcher Thomas Imperiale, M.D., writes that to increase screening rates for colorectal cancers, we need more convenient and less invasive screening tests. An infrequently used type of fecal sampling test, which has had Federal Drug Administration approval since 2001, may meet that need he says.
Similar news · Read more »
Geisinger scientist seeks cure for Lou Gehrig's disease, creating device to find treatment
07-30-2007 · EurekAlert!
Geisinger Health System researcher Glenn Gerhard is seeking a cure for a devastating neurodegenerative condition, amyotrophic lateral sclerosis, or Lou Gehrig's disease. A cure -- or perhaps a treatment -- might be found in the right mix of the millions of drugs and drug compounds developed in laboratories across the world. With the help of some college students, Gerhard is designing a device to efficiently test those compounds. And that's bringing us closer to a cure.
Similar news · Read more »
DNA Highly Promising Predictor For Successful Treatment Of Alcoholics
10-05-2006 · ScienceDaily
According to Dutch researcher Wendy Ooteman, the biological and genetic characteristics of alcoholics can predict which drugs will best suppress the desire to drink. Naltrexone and acamprosate are drugs that are supposed to suppress the desire for a drink. The researcher investigated which patient characteristics were responsible for predicting the drug that would work best.
Similar news · Read more »